Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain

Mult Scler Relat Disord. 2020 Jul:42:102185. doi: 10.1016/j.msard.2020.102185. Epub 2020 May 7.

Authors

Paloma Montero-Escribano¹, Jorge Matías-Guiu¹, Patricia Gómez-Iglesias¹, Jesús Porta-Etessam¹, Vanesa Pytel¹, Jordi A Matias-Guiu²

Affiliations

¹ Department of Neurology, San Carlos Health Research Institute, Universidad Complutense.28040 Madrid, Spain.
² Department of Neurology, San Carlos Health Research Institute, Universidad Complutense.28040 Madrid, Spain. Electronic address: jordimatiasguiu@hotmail.com.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Betacoronavirus
COVID-19
Coronavirus Infections
Humans
Multiple Sclerosis*
Pandemics
Pneumonia, Viral
SARS-CoV-2
Spain

Substances

Antibodies, Monoclonal, Humanized
ocrelizumab